Bank of America
VAXX

Bank of America’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Bank of America’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-91,981
Closed -$66K – 8546
2024
Q1 		$66K Sell
91,981
-266,275
-74% -$193K ﹤0.01% 6425
2023
Q4 		$305K Sell
358,256
-141,301
-28% -$136K ﹤0.01% 5828
2023
Q3 		$684K Buy
499,557
+28,499
+6% +$61.7K ﹤0.01% 5086
2023
Q2 		$1.19M Buy
471,058
+159,468
+51% +$338K ﹤0.01% 4645
2023
Q1 		$707K Sell
311,590
-240,833
-44% -$610K ﹤0.01% 5139
2022
Q4 		$773K Sell
552,423
-2,650,797
-83% -$4.45M ﹤0.01% 5055
2022
Q3 		$6.34M Sell
3,203,220
-12,671
-0.4% -$26.4K ﹤0.01% 3084
2022
Q2 		$5.05M Buy
3,215,891
+3,200,033
+20,179% +$12.1M ﹤0.01% 3387
2022
Q1 		$68K Buy
15,858
+15,658
+7,829% +$86.5K ﹤0.01% 7036
2021
Q4 		$1K Buy
+200
New +$2.07K ﹤0.01% 8110

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Bank of America's VAXX Position: Q2 2024 in Review

Bank of America sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 91,981 shares — an estimated $66K sold.

Bank of America first reported a position in VAXX in Q4 2021 and held it in 10 quarters. The position peaked at $6.34M in Q3 2022. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Bank of America reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bank of America sold 91,981 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $66K.
  • Bank of America first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2021 and held it in 10 quarters.
  • Bank of America's Vaxxinity, Inc. Class A Common Stock position peaked at $6.34M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.